Inside Indiana Business |
Lilly Pulls Plug on Potential Diabetes Treatment
Inside Indiana Business (NYSE: LLY) says it is discontinuing development of a highly-regarded potential diabetes treatment. Lilly Diabetes President Enrique Conterno says, while the company was encouraged by efficacy data for basal insulin peglispro, “we know that moving … Lilly stops development of diabetes treatmentReuters Lilly Abandons Diabetes TreatmentTelegraphTimes.com (blog) Eli Lilly Ends Development of Potential Diabetes TreatmentPharmaceutical Processing all 47 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.